Nicole Vitullo - Net Worth and Insider Trading

Nicole Vitullo Net Worth

The estimated net worth of Nicole Vitullo is at least $40 Million dollars as of 2024-04-24. Nicole Vitullo is the 10% Owner of Zogenix Inc and owns about 825,323 shares of Zogenix Inc (ZGNX) stock worth over $22 Million. Nicole Vitullo is the Director of Achillion Pharmaceuticals Inc and owns about 2,391,407 shares of Achillion Pharmaceuticals Inc (ACHN) stock worth over $16 Million. Nicole Vitullo is also the 10% Owner of Alimera Sciences Inc and owns about 279,297 shares of Alimera Sciences Inc (ALIM) stock worth over $997,090. Besides these, Nicole Vitullo also holds Ocera Therapeutics Inc (OCRX) , Clovis Oncology Inc (CLVSQ) , Esperion Therapeutics Inc (ESPR) , Marinus Pharmaceuticals Inc (MRNS) , Orexigen Therapeutics Inc (OREXQ) , Regado Biosciences Inc (RGDO) . Details can be seen in Nicole Vitullo's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Nicole Vitullo has not made any transactions after 2021-03-15 and currently still holds the listed stock(s).

Transaction Summary of Nicole Vitullo

To

Nicole Vitullo Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nicole Vitullo owns 30 companies in total, including Esperion Therapeutics Inc (ESPR) , Achillion Pharmaceuticals Inc (ACHN) , and Marinus Pharmaceuticals Inc (MRNS) among others .

Click here to see the complete history of Nicole Vitullo’s form 4 insider trades.

Insider Ownership Summary of Nicole Vitullo

Ticker Comapny Transaction Date Type of Owner
ESPR Esperion Therapeutics Inc 2019-03-19 director & 10 percent owner
ACHN Achillion Pharmaceuticals Inc 2020-01-28 director
MRNS Marinus Pharmaceuticals Inc 2021-03-15 director & 10 percent owner
OBLN Obalon Therapeutics Inc 2019-08-06 10 percent owner
ADYX Adynxx Inc 2019-05-03 10 percent owner
BNGO Bionano Genomics Inc 2018-08-21 10 percent owner
DRNA Dicerna Pharmaceuticals Inc 2017-12-18 10 percent owner
OCRX Ocera Therapeutics Inc 2017-12-11 10 percent owner
RGDO Regado Biosciences Inc 2016-11-01 10 percent owner
CLCD CoLucid Pharmaceuticals Inc 2016-09-09 10 percent owner
CPXX Celator Pharmaceuticals Inc 2016-07-12 director
EVOK Evoke Pharma Inc 2013-09-24 10 percent owner
SNDX Syndax Pharmaceuticals Inc 2016-03-02 10 percent owner
GKOS Glaukos Corp 2015-06-24 10 percent owner
LIFE aTyr Pharma Inc 2015-05-06 10 percent owner
EVFM Evofem Biosciences Inc 2014-11-19 10 percent owner
ATRA Atara Biotherapeutics Inc 2014-10-15 10 percent owner
VCYT Veracyte Inc 2013-10-29 10 percent owner
OTIC Otonomy Inc 2014-08-12 10 percent owner
ALDX Aldeyra Therapeutics Inc 2014-05-01 10 percent owner
AKAOQ Achaogen Inc 2014-03-17 10 percent owner
ALIM Alimera Sciences Inc 2011-06-02 10 percent owner
TNDM Tandem Diabetes Care Inc 2013-11-13 10 percent owner
CLVSQ Clovis Oncology Inc 2011-11-21 10 percent owner
OREXQ Orexigen Therapeutics Inc 2011-12-22 10 percent owner
ZGNX Zogenix Inc 2011-09-16 10 percent owner
VNDA Vanda Pharmaceuticals Inc 2006-04-12 10 percent owner
PRTK Paratek Pharmaceuticals Inc 2006-05-09 10 percent owner
NUVA NuVasive Inc 2004-05-12 10 percent owner
RSLS Reshape Lifesciences Inc 2016-10-05 10 percent owner

Nicole Vitullo Latest Holdings Summary

Nicole Vitullo currently owns a total of 9 stocks. Among these stocks, Nicole Vitullo owns 825,323 shares of Zogenix Inc (ZGNX) as of November 29, 2010, with a value of $22 Million and a weighting of 55.47%. Nicole Vitullo owns 2,391,407 shares of Achillion Pharmaceuticals Inc (ACHN) as of November 11, 2015, with a value of $16 Million and a weighting of 40.73%. Nicole Vitullo also owns 279,297 shares of Alimera Sciences Inc (ALIM) as of June 2, 2011, with a value of $997,090 and a weighting of 2.51%. The other 6 stocks Ocera Therapeutics Inc (OCRX) , Clovis Oncology Inc (CLVSQ) , Esperion Therapeutics Inc (ESPR) , Marinus Pharmaceuticals Inc (MRNS) , Orexigen Therapeutics Inc (OREXQ) , Regado Biosciences Inc (RGDO) have a combined weighting of 1.29% among all his current holdings.

Latest Holdings of Nicole Vitullo

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ZGNX Zogenix Inc 2010-11-29 825,323 26.68 22,019,618
ACHN Achillion Pharmaceuticals Inc 2015-11-11 2,391,407 6.76 16,165,911
ALIM Alimera Sciences Inc 2011-06-02 279,297 3.57 997,090
OCRX Ocera Therapeutics Inc 2013-07-15 246,386 1.79 441,031
CLVSQ Clovis Oncology Inc 2011-11-21 3,041,950 0.02 45,629
ESPR Esperion Therapeutics Inc 2019-03-19 8,319 2.09 17,387
MRNS Marinus Pharmaceuticals Inc 2021-03-15 3,692 1.45 5,353
OREXQ Orexigen Therapeutics Inc 2011-12-22 301,806 0.01 1,600
RGDO Regado Biosciences Inc 2013-08-27 2,603,208 0.00 0

Holding Weightings of Nicole Vitullo


Nicole Vitullo Form 4 Trading Tracker

According to the SEC Form 4 filings, Nicole Vitullo has made a total of 0 transactions in Zogenix Inc (ZGNX) over the past 5 years. The most-recent trade in Zogenix Inc is the acquisition of 293,750 shares on November 29, 2010, which cost Nicole Vitullo around $9 Million.

According to the SEC Form 4 filings, Nicole Vitullo has made a total of 0 transactions in Achillion Pharmaceuticals Inc (ACHN) over the past 5 years. The most-recent trade in Achillion Pharmaceuticals Inc is the sale of 550,000 shares on November 11, 2015, which brought Nicole Vitullo around $6 Million.

According to the SEC Form 4 filings, Nicole Vitullo has made a total of 0 transactions in Alimera Sciences Inc (ALIM) over the past 5 years. The most-recent trade in Alimera Sciences Inc is the sale of 461 shares on June 2, 2011, which brought Nicole Vitullo around $55,589.

More details on Nicole Vitullo's insider transactions can be found in the Insider Trading History of Nicole Vitullo table.

Insider Trading History of Nicole Vitullo

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Nicole Vitullo Trading Performance

GuruFocus tracks the stock performance after each of Nicole Vitullo's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nicole Vitullo is 15.68%. GuruFocus also compares Nicole Vitullo's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nicole Vitullo within 3 months outperforms 5 times out of 19 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Nicole Vitullo's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Nicole Vitullo

Average Return

-5.07%

Average return per transaction

Outperforming Transactions

32%

6 out of 19 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 14.92 15.68 22.11 -5.07 -16.01 -7.3
Relative Return to S&P 500(%) 11.38 10.65 14.06 -17.55 -27.54 -18.79

Nicole Vitullo Ownership Network

Ownership Network List of Nicole Vitullo

No Data

Ownership Network Relation of Nicole Vitullo


Nicole Vitullo Owned Company Details

What does Esperion Therapeutics Inc do?

Who are the key executives at Esperion Therapeutics Inc?

Nicole Vitullo is the director & 10 percent owner of Esperion Therapeutics Inc. Other key executives at Esperion Therapeutics Inc include Chief Commercial Officer Eric Warren , Chief Operating Officer Sheldon L. Koenig , and Chief Medical Officer Joanne M. Foody .

Esperion Therapeutics Inc (ESPR) Insider Trades Summary

Over the past 18 months, Nicole Vitullo made no insider transaction in Esperion Therapeutics Inc (ESPR). Other recent insider transactions involving Esperion Therapeutics Inc (ESPR) include a net sale of 7,644 shares made by Eric Warren , a net sale of 9,821 shares made by Joanne M. Foody , and a net purchase of 7,560 shares made by Sheldon L. Koenig .

In summary, during the past 3 months, insiders sold 0 shares of Esperion Therapeutics Inc (ESPR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 37,542 shares of Esperion Therapeutics Inc (ESPR) were sold and 59,611 shares were bought by its insiders, resulting in a net purchase of 22,069 shares.

Esperion Therapeutics Inc (ESPR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Esperion Therapeutics Inc Insider Transactions

No Available Data

Nicole Vitullo Mailing Address

Above is the net worth, insider trading, and ownership report for Nicole Vitullo. You might contact Nicole Vitullo via mailing address: 3030 Science Park Road, San Diego Ca 92121.

Discussions on Nicole Vitullo

No discussions yet.